Overview Present-day serverless systems can scale from zero to hundreds of GPUs within seconds to handle unexpected increases ...

Truelist releases 20+ free, open-source SDKs and framework integrations for email validation — Node, Python, React, ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

GL Communications Inc., a global provider of voice testing solutions, announces significant enhancements to its SIP testing p ...

Langraph Deploy CLI lets developers create, test, and deploy AI agents from the terminal, with templates and langraph deploy ...

Securing dynamic AI agent code execution requires true workload isolation—a challenge Cloudflare’s new API was built to solve ...

You don't need to be a developer to build your own crypto bot. Here's how traders are doing it in 30 minutes, for free.

No more fighting an endless article backlog.

With Gemini and a simple Python script, I rebuilt YouTube email alerts. Now I won't miss another comment. Here's how you can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...